Latest News
-
Tossed Medicine, Delayed Housing: How Homeless Sweeps Are Thwarting Medicaid’s Goals
-
Decades of National Suicide Prevention Policies Haven’t Slowed the Deaths
-
‘What Happens Three Months From Now?’ Mental Health After Georgia High School Shooting
-
The First Year of Georgia’s Medicaid Work Requirement Is Mired in Red Tape
-
Over 57 Million Could Be Clinically Eligible for GLP-1 Drugs
Over two in five (57.4 million) adults under 65 with private insurance could be eligible under clinical criteria for GLP-1 drugs used to treat people with type 2 diabetes, obesity, or excess weight and weight-related health issues.
-
Allowing Medicare to Negotiate Drug Prices Remains Popular; Most Are Unaware of the Law
A large majority of voters across politcal parties support allowing the federal government to negotiate the price of some prescription drugs for people with Medicare. But nearly two thirds of voters are unaware or unsure that there is a law allowing this.
-
Vaccine Misinformation Spreads as Kids Head Back to School
In this installment of the Health Misinformation Monitor, vaccine hesitancy and misinformation around MMR (measles, mumps, and rubella) vaccines as children return to school. Plus COVID-19 vaccine misinformation and false claims about mpox.
-
Beyond the Data by Drew Altman
In his regular Beyond the Data columns, CEO Drew Altman discusses what the data, polls, and journalism produced by KFF mean for policy and for people.